U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610967) titled 'Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections' on May 14.
Brief Summary: The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
COVID-19 Respiratory Infection
Influenza
Intervention:
DEVICE: RD-X19
* Subject will be given the RD-X19 device and shown how to use the device
* Subjec...